| CAS |
Chemical Name |
Cat.No. |
MolFormula |
| 139092-78-7 |
4,4',4''-Tris(carbazol-9-yl)-triphenylamine |
TS93276 |
C54H36N4 |
| 138982-67-9 |
zIprasidone hydrochloride |
TS93275 |
C21H22Cl2N4OS |
| 138687-69-1 |
Pentafluorophenyl diphenylphosphinate |
TS93274 |
C18H10F5O2P |
| 138526-69-9 |
1-Bromo-3,4,5-trifluorobenzene |
TS93273 |
C6H2BrF3 |
| 137863-17-3 |
N-[2'-(1h-tetrazol-5-yl)biphenyl-4-yl methyl]-n-valeryl-(l)-valine methyl ester |
TS93271 |
C25H31N5O3 |
| 1378388-16-9 |
(2S,4s)-1-(tert-butoxycarbonyl)-4-(methoxymethyl)pyrrolidine-2-carboxylic acid |
TS93270 |
C12H21NO5 |
| 1378387-81-5 |
1-(7-Bromo-9,9-difluoro-9h-fluoren-2-yl)-2-chloro-ethanone |
TS93269 |
C15H8BrClF2O |
| 13781-37-8 |
2-Iodo-5-phenylthiophene |
TS93268 |
C10H7IS |
| 137644-51-0 |
4-(Trans-4-propylcyclohexyl)-4'-(trifluoromethyl)-1,1'-biphenyl |
TS93267 |
C22H25F3 |
| 137234-71-0 |
Voriconazole |
TS93266 |
C16H14F3N5O |
| 137234-63-0 |
(2R,3s/2s,3r)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol |
TS93265 |
C16H14F3N5O |
| 137234-62-9 |
Voriconazole |
TS93264 |
C16H14F3N5O |
| 13682-92-3 |
aLuminium glycinate |
TS93263 |
C6H12AlN3O6 |
| 136630-39-2 |
2,7-Dibromo-9h-carbazole |
TS93262 |
C12H7Br2N |
| 136434-34-9 |
Duloxetine |
TS93261 |
C18H19NOS |
| 136337-67-2 |
3-(2,6-Diisopropyl-4-phenoxyphenyl)-1-tert-butylurea |
TS93260 |
C23H32N2O2 |
| 136285-69-3 |
Ethyl-3-amine-2-[(2'-cyanobiphenyl-4-yl)-amino]-benzoate |
TS93259 |
C23H21N3O2 |
| 136285-65-9 |
Ethyl-2-t-butoxy-2-carboxylamino-3-nitrobenzoate |
TS93258 |
C14H18N2O6 |
| 13616-82-5 |
2,4-Dimethylthiophenol |
TS93257 |
C8H10S |
| 1361227-58-8 |
3-Dromo-9,9'-spirobifluorene |
TS93256 |
C25H15Br |
| 13578-51-3 |
1-(4-Methylphenylsulfonyl)-1,2,4-triazole |
TS93255 |
C9H9N3O2S |
| 13573-18-7 |
Calcium phosphate |
TS93254 |
Ca3O8P2 |
| 135544-68-2 |
N-(allyloxycarbonyloxy)succinimide |
TS93253 |
C8H9NO5 |
Tetra